Indaptus Therapeutics (INDP) Institutional Ownership $0.94 +0.05 (+5.39%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Indaptus Therapeutics (NASDAQ:INDP)CurrentInstitutional OwnershipPercentage7.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.88KNumber ofInstitutional Sellers(last 12 months)0 Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INDP Institutional Buying and Selling by Quarter Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Indaptus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC14,232$32K0.0%N/A0.167% 11/9/2023 Investment House LLC102,849$283K0.0%-5.0%1.224% 8/25/2023 Strategy Asset Managers LLC45,336$87K0.0%-18.1%0.540% 8/8/2023 Investment House LLC108,282$207K0.0%+13.2%1.289% 10/11/2022 Strategy Asset Managers LLC55,336$120K0.0%N/A0.670% 7/22/2022Stratos Wealth Partners LTD.26,832$70K0.0%-97.7%0.325% 4/26/2022Stratos Wealth Partners LTD.1,188,356$4.75M0.1%-14.4%14.389% 2/9/2022 Investment House LLC95,629$545K0.0%+272.8%1.167% 1/14/2022Stratos Wealth Partners LTD.1,388,356$7.91M0.2%N/A16.952% 11/15/2021 Marshall Wace LLP12,780$100K0.0%N/A0.236% 10/25/2021 Harel Insurance Investments & Financial Services Ltd.2,958$25K0.0%N/A0.055% (Data available from 1/1/2016 forward) INDP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INDP shares? During the previous two years, the following institutional investors and hedge funds held shares of Indaptus Therapeutics shares: Investment House LLC ($283K), and Strategy Asset Managers LLC ($87K), Virtu Financial LLC ($32K).Learn more on INDP's institutional investors. What percentage of Indaptus Therapeutics stock is owned by institutional investors? 7.06% of Indaptus Therapeutics stock is owned by institutional investors. Learn more on INDP's institutional investor holdings. Which institutional investors have been buying Indaptus Therapeutics stock? The following institutional investors have purchased Indaptus Therapeutics stock in the last 24 months: Virtu Financial LLC ($14.23K), and Investment House LLC ($12.65K). How much institutional buying is happening at Indaptus Therapeutics? Institutional investors have bought a total of 26,885 shares in the last 24 months. This purchase volume represents approximately $56.05K in transactions. Which Indaptus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Indaptus Therapeutics stock in the last 24 months: Strategy Asset Managers LLC ($10K), and Investment House LLC ($5.43K). How much institutional selling is happening at Indaptus Therapeutics? Institutional investors have sold a total of 15,433 shares in the last 24 months. This volume of shares sold represents approximately $34.07K in transactions. Related Companies LTRN Major Shareholders CALC Major Shareholders ELEV Major Shareholders VYNE Major Shareholders LEXX Major Shareholders LUMO Major Shareholders OCX Major Shareholders MRKR Major Shareholders DTIL Major Shareholders TPST Major Shareholders This page (NASDAQ:INDP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.